美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
10135-826-10	10135-826	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20250801	N/A	ANDA	ANDA201272	Marlex Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	75 mg/1	1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-826-10)
10135-826-30	10135-826	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20250801	N/A	ANDA	ANDA201272	Marlex Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	75 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-826-30)
10135-826-75	10135-826	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20250801	N/A	ANDA	ANDA201272	Marlex Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	75 mg/1	15 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-826-75)
10135-826-90	10135-826	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20250801	N/A	ANDA	ANDA201272	Marlex Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	75 mg/1	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-826-90)
10135-825-10	10135-825	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20250801	N/A	ANDA	ANDA201272	Marlex Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5 mg/1	1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-825-10)
10135-825-30	10135-825	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20250801	N/A	ANDA	ANDA201272	Marlex Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-825-30)
10135-825-75	10135-825	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20250801	N/A	ANDA	ANDA201272	Marlex Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5 mg/1	15 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-825-75)
10135-825-90	10135-825	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20250801	N/A	ANDA	ANDA201272	Marlex Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5 mg/1	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-825-90)
10135-827-10	10135-827	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20250801	N/A	ANDA	ANDA201272	Marlex Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	150 mg/1	1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-827-10)
10135-827-30	10135-827	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20250801	N/A	ANDA	ANDA201272	Marlex Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	150 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-827-30)
10135-827-75	10135-827	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20250801	N/A	ANDA	ANDA201272	Marlex Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	150 mg/1	15 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-827-75)
10135-827-90	10135-827	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20250801	N/A	ANDA	ANDA201272	Marlex Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	150 mg/1	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-827-90)